பங்கபந்து ஷேக் முஜிப் மருத்துவ பல்கலைக்கழகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published June 29, 2021, 9:39 AM London, United Kingdom Delayed second and third doses of the AstraZeneca vaccine boost immunity against COVID-19, a study by Oxford University, which developed the jab with the British-Swedish firm, said on Monday. An interval of up to 45 weeks between the first and second dose of the AstraZeneca vaccine led to an enhanced immune response, rather than compromising immunity, the study said. Vials of the Oxford-AstraZeneca COVID-19 vaccine are pictured at the Bangabandhu Sheikh Mujib Medical University Hospital (BSMMU), in Dhaka on June 22, 2021. (Munir Uz zaman / AFP / MANILA BULLETIN) Giving a third dose of the jab more than six months after the second dose also leads to a “substantial increase” in antibodies and induces a “strong boost” to subjects’ immune response, said the pre-print study, meaning that it has yet to be peer-reviewed.

United kingdomCity ofAndrew pollardOxford astrazenecaTeresa lambeMunir uzMatthew snapeOxford universityBangabandhu sheikh mujib medical university hospitalஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்ஆண்ட்ரூ பொழிலர்ட்தெரசா ஆட்டுக்குட்டிமுனீர் ஊஜ்மேத்யூ ஸ்னேப்ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்